Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
« Today's Globe: ex-McLean chief, meningitis death, low fat and ovarian cancer, migraine pill and alcoholics, Israeli doctors and Iraqi patients | Main | Short White Coat: A Jell-O mold of the brain »
Wednesday, October 10, 2007
WSJ blog: Harvard scientist devises way to bring vaccines to the poor, via China
Harvard scientist John Mekalanos (left) came up with a way to make vaccines much more cheaply, but to actually produce them, he had to fly to China, the Wall Street Journal's Health Blog reports.
Mekalanos struck a deal with Gerald Chan, a venture capitalist who is opening a vaccine factory on a tropical island called Hainan, one of the regions China has targeted for foreign investment, the blog says. Harvard will license Mekalanosís method to Chanís Morningside Group. The result will be a company with scientists working in Boston and on Hainan to develop a commercial vaccine.
The deal allows Harvard to license any vaccines the company creates to governments and humanitarian groups in the developing world, Isaac Kohlberg, the chief of Harvardís technology development office, told the WSJ blog. Morningside would be able to sell the vaccine in the developed world.